Form 4: Vericel Corp CEO Dominick Colangelo Executes Stock Options and Sells Shares Under 10b5-1 Plan

Dominick Colangelo, President and CEO of Vericel Corp, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• On May 14 and 15, 2025, Dominick Colangelo, the President and CEO of Vericel Corp, exercised stock options to acquire 14,062 and 14,063 shares of common stock, respectively, at a price of $2.65 per share.
• Concurrently, Colangelo sold 14,062 and 14,063 shares of common stock on the same days at prices of $42.25 and $41.53, respectively.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on December 2, 2024.
• Following these transactions, Colangelo directly owns 260,354 shares of Vericel Corp common stock.
• The stock options exercised were granted on May 22, 2017, and became fully exercisable in quarterly installments, contingent upon continued service to the company.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy. The CEO is exercising options and selling shares, which is a common practice. No indication of significant positive or negative implications.

Positives

• The CEO's continued stock ownership demonstrates ongoing investment in the company's future.
• The use of a 10b5-1 trading plan suggests a structured and transparent approach to stock transactions, mitigating concerns about insider trading.

Negatives

• The sale of shares by the CEO, even under a 10b5-1 plan, could be perceived negatively by some investors.

Risks

• Executive stock sales, even under pre-arranged plans, can sometimes create short-term market uncertainty.
• Changes in executive compensation or stock ownership could impact investor sentiment.

Industry Context

Executive stock transactions are common in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's future prospects. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
• Rule 10b5-1 trading plans are widely used by corporate insiders to manage their stock sales in a transparent and compliant manner.
• Comparing Colangelo's stock ownership and trading activity to those of executives at similar-sized biotech companies (e.g., companies with similar market capitalization and revenue) could provide additional context.

Stakeholder Impact

• Shareholders may react to the stock sales, although the 10b5-1 plan should mitigate concerns about insider trading.
• Employees may be interested in the CEO's stock activity as it relates to the company's overall performance.

Key Dates

Keywords

Vericel Corp, Dominick Colangelo, Stock Options, Rule 10b5-1, SEC Form 4, Insider Trading, Executive Compensation, Stock Sale